Trader Note — 9837 total
Massimo Group heads into a pivotal week with short sellers rebuilding positions at speed — even as the stock sits flat and the latest earnings print offered a mixed-but-improving picture. The most striking data point…
TuHURA Biosciences enters its May 22 earnings event in an uncomfortable position: the stock is down 27% over the past month to $2.31, short sellers hold nearly a quarter of the free float, and the borrow market has…
Healthy Choice Wellness Corp. enters the back half of May with a fresh earnings miss on the books and shorts quietly retreating — a combination that leaves the stock's near-term narrative more about fundamental…
LZMH, the Nasdaq-listed LZ Technology Holdings, had one of the most dramatic short-side repositioning weeks in its recent history — yet the underlying setup remains more curious than threatening. Short interest…
ARS Pharmaceuticals enters the post-Q1 period in a compressed vice: a quarterly earnings miss sent the stock down 6.5% on Friday to $7.43, while the lending market for its shares is as tight as it has been all…
Expion360 heads into the aftermath of its Q1 results with short sellers already in full retreat — yet the stock is still falling. The defining tension this week is the disconnect between positioning and price. Short…
KinderCare Learning Companies beat first-quarter earnings estimates on May 14, watched two analysts raise their price targets the following morning — then dropped 8% on Friday. That disconnect is the story this…
Candel Therapeutics heads into its May 21 earnings print with a heavyweight short base, a stock up 72% over the past month, and a conflicted Street watching whether clinical momentum can justify a rally that bears…
Rani Therapeutics Holdings reported Q1 results after the bell on May 15 — beating the modest revenue estimate and narrowing its net loss — but paired the print with a CFO departure announcement. That combination of…
ENSC heads into its May 20 earnings event carrying the most aggressive short-side lending profile it has seen all year — a violent, week-long repricing that leaves the stock at $0.28 and the borrow market in a state of…
DT Midstream enters the back half of May with the Street scrambling to keep up — five firms have raised price targets in two weeks, and the stock just printed a fresh high at $148.08. The analyst story is the cleanest…
Hydrofarm Holdings reported Q1 results on May 15 and missed on both lines. Yet the real story this week is that short sellers had been cutting positions aggressively before the numbers hit — a classic pre-earnings exit…
SOS Limited heads into its May 22 earnings with shorts quietly rebuilding and the borrow market showing meaningful but easing pressure — a setup worth watching given the stock's history of outsized post-earnings…
Skillz heads into its Q1 2026 earnings call on Monday with short sellers rebuilding positions, borrow costs surging, and options traders leaning decisively toward calls — a divergence that sets up a genuinely charged…
WETH fell 15.7% over the past week to $1.50, erasing nearly all of its modest one-month gain and bringing the micro-cap touchscreen maker back toward the lower end of its recent trading range. The week's most notable…
Foghorn Therapeutics enters the back half of May with momentum firmly against it — a Q1 revenue miss triggered a 14.6% weekly decline, and the stock now trades at $3.79, down more than 20% over the past month. The Q1…
NXXT heads into Monday's earnings conference call with a notable twist: the stock posted a Q1 earnings beat after the close on Friday, yet it closed the week down 18%, trading at just $0.28. The price action tells the…
CISO Global entered its Q1 earnings week with short sellers adding aggressively to positions — and the stock sliding 11% on the day results hit. Short interest has been the dominant story here for the past fortnight.…
VYNE Therapeutics just posted Q1 results after market close on May 15 — and the print is the week's defining tension. EPS came in at –$0.08, beating the –$0.18 estimate by ten cents. Revenue of $86,000 missed the…
TFPM delivered record Q1 results on May 5 — and has spent the week being sold anyway. The paradox at the centre of this week's setup is straightforward. Adjusted EPS of $0.45 beat estimates and revenues of nearly $147…
